SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma

Clinical trial NCT00796731 · COMPLETED

Trial details

NCT number: NCT00796731
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Non-Hodgkin

Start date: 2008-10-01
Primary completion: 2012-06-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.